Delivery Order SPE2DR25D3004-SPE2DR26FXPD7
- Not listed
- The Defense Logistics Agency awarded a $13,075.97 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens, 40 mg/0.4 mL dosage. This contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,434.52 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens at 40 mg/0.4 mL. The contract, designated as a firm fixed-price delivery order, was competitively awarded with no set-aside provisions and carries an ultimate completion date of December 4, 2025. AmerisourceBergen will perform the work from its corporate headquarters in Conshohocken, Pennsylvania. This award is a child order issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, due for completion by June 2, 2025. The award was issued on May 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $3,979.90 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) pen 40 mg/0.4 mL units, with an ultimate completion date of December 1, 2025. This non-competitive delivery order represents a firm fixed-price transaction under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $4,843.93 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The contract represents a single delivery order...
- The Defense Logistics Agency awarded a $13,657.29 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL of pharmaceutical product. The contract is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order issued under a larger contract vehicle. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $13,040.64 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL formulation. This is a firm fixed price, non-set-aside contract with a completion date of December 12, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.94 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL formulation. This non-competitive, firm fixed-price delivery order was issued on December 5, 2025, with an ultimate completion date of December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,759.15 for HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL, by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation has an ultimate completion date of September 9, 2025 and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction...
- The Defense Logistics Agency awarded a delivery order valued at $19,164.60 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary pharmaceutical distribution...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXPD7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,457.75 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens, 80 mg/0.8 mL formulation. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of December 5, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a single transaction under a larger contracting vehicle supporting the federal government's pharmaceutical procurement needs. This award is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to military and veteran healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement requirements through competitive awards, demonstrating capability across multiple therapeutic domains and transaction sizes. The DLA Troop Support Medical contract supports critical healthcare delivery to the Defense Health Agency, U.S. Coast Guard, and other government healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 12/3/25 |